Xtrackers MSCI Genomic Healthcare Innovation ETF 1C
26,39
EUR
+0,06
EUR
+0,21
%
30,50
USD
-0,57
USD
-1,83
%
Werbung
Werbung
Xtrackers MSCI Genomic Healthcare Innovation ETF 1C Kurs - 1 Jahr
Baader Bank Berlin gettex Düsseldorf Lang & Schwarz FTI München SIX SX USD SIX SX Tradegate XETRA Quotrix
NAV
Baader Bank
Berlin
gettex
Düsseldorf
Lang & Schwarz
FTI
München
SIX SX USD
SIX SX
Tradegate
XETRA
Quotrix
| Emittent | DWS Investment (ETF) |
| Auflagedatum | 12.07.2022 |
| Kategorie | Aktien |
| Fondswährung | USD |
| Benchmark | |
| Ausschüttungsart | Thesaurierend |
| Total Expense Ratio (TER) | 0,30 % |
| Fondsgröße | 5.612.169,75 |
| Replikationsart | Physisch vollständig |
| Morningstar Rating | - |
Anlageziel Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc
So investiert der Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc: The investment objective of the Fund is to track the performance before fees and expenses of an index which is designed to reflect the performance of the shares of large, medium, and small-capitalisation companies that derive, or are expected to derive, significant revenues from technological innovation in the genomic healthcare sector and which promote, among other characteristics, environmental and social characteristics.
Der Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: DBX0R2
| 3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2025 | |
|---|---|---|---|---|---|---|
| Performance | +8,22 % | +6,32 % | -2,30 % | -7,08 % | - | +5,15 % |
| Outperformance ggü. Kategorie | +7,30 % | +7,85 % | +3,85 % | -7,09 % | - | +6,94 % |
| Max Verlust | - | - | -17,30 % | -23,25 % | - | - |
| Kurs | 24,43 $ | 26,26 $ | 28,09 $ | - | - | 30,50 $ |
| Hoch | - | - | 32,10 $ | - | - | - |
| Tief | - | - | 24,38 $ | - | - | - |
Kennzahlen ISIN: IE000KD0BZ68
| Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
|---|---|---|---|---|
| Volatilität | 16,12 % | 18,28 % | ||
| Sharpe Ratio | -0,54 | -0,23 |
Werbung
Werbung
Zusammensetzung WKN: DBX0R2
Größte Positionen ISIN: IE000KD0BZ68
| Name | ISIN | Marktkapitalisierung | Gewichtung |
|---|---|---|---|
| Lonza Group Ltd | CH0013841017 | 40.581.342.754 € | 4,35 % |
| AbbVie Inc | US00287Y1091 | 318.299.641.069 € | 4,29 % |
| Vertex Pharmaceuticals Inc | US92532F1003 | 84.812.466.414 € | 4,28 % |
| Agilent Technologies Inc | US00846U1016 | 29.957.449.344 € | 4,24 % |
| Illumina Inc | US4523271090 | 12.495.158.352 € | 4,23 % |
| Danaher Corp | US2358511028 | 117.405.461.161 € | 4,18 % |
| Roche Holding AG | CH0012032048 | 226.703.840.055 € | 4,00 % |
| Abbott Laboratories | US0028241000 | 191.678.789.035 € | 3,91 % |
| Bristol-Myers Squibb Co | US1101221083 | 81.705.257.960 € | 3,79 % |
| Natera Inc | US6323071042 | 19.839.381.849 € | 3,63 % |
| Summe Top 10 | 40,90 % | ||
Weitere ETFs mit gleicher Benchmark
| ETF | TER | Größe | Perf 1J |
|---|---|---|---|
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc | 0,30 % | 5,61 Mio. $ | -2,30 % |
| iShares MSCI USA ESG Enhanced CTB UCITS ETF USD Inc | 0,07 % | 18,75 Mrd. $ | +18,13 % |
| SPDR Bloomberg U.S. Corporate Scored UCITS ETF | 0,15 % | 6,46 Mrd. $ | +3,55 % |
| Amundi Index Solutions - Amundi EUR Corporate Bond ESG UCITS ETF DR - Hedged USD (C) | 0,18 % | 6,27 Mrd. $ | +5,99 % |
| UBS MSCI World Socially Responsible UCITS ETF USD acc | 0,20 % | 5,44 Mrd. $ | +11,48 % |